Sep 30, 2019

United Therapeutics Q3 2019 Earnings Report

Total Revenue
$402M
Previous year: $413M
-2.7%
EPS
$3.83
Previous year: $3.98
-3.8%
Gross Profit
$369M
Previous year: $361M
+2.1%
Cash and Equivalents
$720M
Previous year: $656M
+9.7%
Free Cash Flow
$172M
Previous year: $163M
+5.4%
Total Assets
$4B
Previous year: $3.41B
+17.2%

United Therapeutics

United Therapeutics

United Therapeutics Revenue by Segment

Revenue & Expenses

Visualization of income flow from segment revenue to net income